Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 17 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 10369173

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Capricor, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  2. US 10357553

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  3. US 10329353

    Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells

    The Board of Regents of the University of Texas System · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  4. US 10307444

    Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  5. US 10300150

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Aura Biosciences, Inc. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  6. US 10300149

    Compositions for enhancing transport of molecules into cells

    Sarepta Therapeutics, Inc. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  7. US 10287606

    Genomic engineering of pluripotent cells

    Fate Therapeutics, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  8. US 10278372

    Genetically modified cells, tissues, and organs for treating disease

    Regents of the University of Minnesota · Granted May 7, 2019 · Expires May 2, 2039

    granted

  9. US 10273274

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  10. US 10259845

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  11. US 10253294

    Galactose oxidase treatment of dendritic cells to improve their immunogenicity

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  12. US 10226488

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  13. US 10226485

    Multipotent adult stem cells and methods for isolation

    Regents of the University of Minnesota · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  14. US 10227567

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  15. US 10226487

    Derivation and self-renewal of lsl1+ cells and uses thereof

    IsletOne AB · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  16. US 10206875

    Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells

    Northwestern University · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  17. US 10202578

    Chicken cells for improved virus production

    The Pirbright Institute · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  18. US 10196613

    Stem cells for modeling type 2 diabetes

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  19. US 10190097

    Method and composition for inducing human pluripotent stem cells

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  20. US 10188769

    Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  21. US 10159727

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  22. US 10155796

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  23. US 10138466

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  24. US 10131880

    Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications

    The Regents of the University of California · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.